| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/17/2005 | WO2005109007A1 Stimulated detection of sample compounds |
| 11/17/2005 | WO2005109006A1 Method of judging non-alcoholic steatohepatitis |
| 11/17/2005 | WO2005109005A1 Methods for determining conformational changes and self-assembly of proteins |
| 11/17/2005 | WO2005109004A2 Disease related protein aggregation |
| 11/17/2005 | WO2005109003A2 Method for characterising compounds |
| 11/17/2005 | WO2005109002A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 11/17/2005 | WO2005109001A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 11/17/2005 | WO2005109000A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 11/17/2005 | WO2005108999A2 Diagnostic and therapeutic use of kcnj6 for alzheimer’s disease |
| 11/17/2005 | WO2005108998A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) |
| 11/17/2005 | WO2005108997A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 6 (dpp6) |
| 11/17/2005 | WO2005108996A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 10 (dpp10) |
| 11/17/2005 | WO2005108995A2 Compositions, test kits and methods for detecting helicobacter pylori |
| 11/17/2005 | WO2005108994A1 Fluorescence resonance energy transfer enzyme substrates |
| 11/17/2005 | WO2005108993A2 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 6 (map3k6) |
| 11/17/2005 | WO2005108992A1 Microarray of three-dimensional heteropolymer microstructures and method therefor |
| 11/17/2005 | WO2005108991A2 Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter |
| 11/17/2005 | WO2005108990A2 Methods of treating demyelinating disorders |
| 11/17/2005 | WO2005108989A2 Assay for antibodies |
| 11/17/2005 | WO2005108988A2 Real time method of detecting acute inflammatory conditions |
| 11/17/2005 | WO2005108987A2 Determination of osteoprotegerin for the prognosis of cardiovascular disorders |
| 11/17/2005 | WO2005108986A1 A diagnostic method of asthma using baff as a diagnostic marker |
| 11/17/2005 | WO2005108985A1 Method of judging systemic arteriosclerosis and judgement reagent |
| 11/17/2005 | WO2005108984A2 Methods and systems for detection, identification and quantitation of macrolides and their impurities |
| 11/17/2005 | WO2005108983A1 Cell permeability assay in a living array of multiple cell types and multiple layers of a porous substrate |
| 11/17/2005 | WO2005108982A1 Methods for identifying compounds for treating diabetes mellitus |
| 11/17/2005 | WO2005108981A1 A method of cell isolation |
| 11/17/2005 | WO2005108980A1 Method for the determination of body odor |
| 11/17/2005 | WO2005108979A1 Kit for assaying potency of peripheral mononuclear blood cell to bind to polysaccharide |
| 11/17/2005 | WO2005108978A1 Method for monitoring a polymerization in a three-dimensional sample |
| 11/17/2005 | WO2005108977A2 Methods and systems for detection of macrolides |
| 11/17/2005 | WO2005108971A2 Fast perfusion system and patch clamp technique utilizing an interface chamber system having high throughput and low volume requirements |
| 11/17/2005 | WO2005108968A1 Biosensor, container for biosensor, and biosensor measuring apparatus |
| 11/17/2005 | WO2005108967A1 Method and device for inspecting penetration of liquid |
| 11/17/2005 | WO2005108960A1 Sensor, measuring equipment and measuring method |
| 11/17/2005 | WO2005108958A1 Microfluidic preconditioning of (bio) fluids for reagent-free infrared clinical analysis and diagnostics |
| 11/17/2005 | WO2005108953A2 Gas monitor using electrochemical cell and metod of operating |
| 11/17/2005 | WO2005108949A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 11/17/2005 | WO2005108627A2 Electrophoretic interactive spectral methods and devices for the detection and/or characterization of biological particles |
| 11/17/2005 | WO2005108625A2 Method for preparing substrates having immobilized molecules and substrates |
| 11/17/2005 | WO2005108623A2 Mn/ca ix/ ca9 and renal cancer prognosis |
| 11/17/2005 | WO2005108615A2 Nucleic-acid programmable protein arrays |
| 11/17/2005 | WO2005108614A2 Reversible and chemically programmable micelle assembly with dna block-copolymer amphiphiles |
| 11/17/2005 | WO2005108613A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 11/17/2005 | WO2005108607A1 Compositions and methods for treating disorders associated with abnormal phosphate metabolism |
| 11/17/2005 | WO2005108604A2 Device and method for detecting molecular interactions |
| 11/17/2005 | WO2005108602A1 Method for the isolation of specific molecules which bind in a highly selective manner to selected target molecules |
| 11/17/2005 | WO2005108600A1 Gm3 synthase as a therapeutic target in microvascular complications of diabetes |
| 11/17/2005 | WO2005108599A2 Compositions and methods for treatment of protein misfolding diseases |
| 11/17/2005 | WO2005108598A1 Assay for drug discovery based on in vitro differentiated cells |
| 11/17/2005 | WO2005108597A2 Process for high throughput liquid or gas chromatography/mass spectrometry-based biomolecular screening for drug discovery |
| 11/17/2005 | WO2005108575A1 T-type calcium channel splice variant compositions and methods |
| 11/17/2005 | WO2005108574A1 Gm1 PROMOTER AND USE THEREOF |
| 11/17/2005 | WO2005108571A1 Micro-reactor for testing, genetic testing apparatus, and genetic testing method |
| 11/17/2005 | WO2005108569A1 Method of determining breed of pig |
| 11/17/2005 | WO2005108567A1 Method of constructing modified protein |
| 11/17/2005 | WO2005108547A1 Patterned cell network substrate interface and methods and uses thereof |
| 11/17/2005 | WO2005108482A1 Polysaccharide/carbon nanotube composite |
| 11/17/2005 | WO2005108474A1 Thermoplastic plastic and method for producing the same |
| 11/17/2005 | WO2005108429A1 Novel soluble cd14 antigen |
| 11/17/2005 | WO2005108427A2 Method for producing soluble mhc proteins |
| 11/17/2005 | WO2005108426A1 Peptide stabilization |
| 11/17/2005 | WO2005108420A1 Cancer associated antigens |
| 11/17/2005 | WO2005108345A1 Synthesis and biological activity or novel bicyclic aba analogs |
| 11/17/2005 | WO2005108287A2 System and method for hydrocarbon processing |
| 11/17/2005 | WO2005107800A1 Monoclonal antibodies to hepatocyte growth factor |
| 11/17/2005 | WO2005107782A2 Use of a modulator of gene expression in the treatment of cancer |
| 11/17/2005 | WO2005107701A2 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 11/17/2005 | WO2005107491A2 Multi-lectin affinity chromatography and uses thereof |
| 11/17/2005 | WO2005107404A2 Methods and systems for nanoparticle enhancement of signals |
| 11/17/2005 | WO2005107368A2 Planar-resonator based optical chemo- and biosensors |
| 11/17/2005 | WO2005093092A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) |
| 11/17/2005 | WO2005093045A3 Cell concentration and pathogen recovery |
| 11/17/2005 | WO2005090983A3 Membrane assay system including preloaded particles |
| 11/17/2005 | WO2005089082A3 Assay device and method |
| 11/17/2005 | WO2005089080A3 Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders |
| 11/17/2005 | WO2005086965A9 A process and apparatus for improving and controlling the curing of natural and synthetic moldable compounds |
| 11/17/2005 | WO2005083385A3 Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
| 11/17/2005 | WO2005073726A3 Proteome interaction mapping |
| 11/17/2005 | WO2005072205A3 Image analysis and assay system |
| 11/17/2005 | WO2005071102A3 Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators |
| 11/17/2005 | WO2005071100A3 Method for determination of protein modifying or demodifying activity and suitable materials thereof |
| 11/17/2005 | WO2005057218A3 Methods of identifying modulators of apoptosis from parasites and uses thereof |
| 11/17/2005 | WO2005056687A3 Methine-substituted cyanine dye compounds |
| 11/17/2005 | WO2005054850A3 Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy |
| 11/17/2005 | WO2005050203A3 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| 11/17/2005 | WO2005049802A3 Anti-hydroxylase antibodies and uses thereof |
| 11/17/2005 | WO2005049063A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 11/17/2005 | WO2005048823A3 Modeling of systemic inflammatory response to infection |
| 11/17/2005 | WO2005042716A3 Nucleic acid binding oligonucleotides |
| 11/17/2005 | WO2005030985A3 Use of amino acid sequences involved in the elongation of fatty acids in identifying and/or developing compounds for preventing and/or treating metabolic diseases |
| 11/17/2005 | WO2005026688A3 Sampling management for a process analysis tool to minimize sample usage and decrease sampling time |
| 11/17/2005 | WO2005023311A3 Novel targets for the treatment of retina diseases |
| 11/17/2005 | WO2005016874A3 Crown ether derivatives |
| 11/17/2005 | WO2004097369A3 Fragmentation-based methods and systems for de novo sequencing |
| 11/17/2005 | WO2004083405A8 Separation and accumulation of subcellular components, and proteins derived therefrom |
| 11/17/2005 | WO2004070006A3 Nucleic acid antigens embedded in thermoplastic |
| 11/17/2005 | WO2004030719A9 Hemostatic puncture closure with depth indicator |
| 11/17/2005 | WO2004024087A3 Methods of diagnosing and treating hyperproliferative disorders |
| 11/17/2005 | WO2003106967A3 Method of evaluating myelosuppressive state |